In another study, rivaroxaban was demonstrated to attenuate deep venous thrombosis in a rat model by targeting NF-κB signaling pathway in endothelial cells, more specifically downregulating IκB levels as well as NF-κB levels and activity and thereby performing anti-inflammatory and pro-fibrinolytic functions [144]. This evidence concerns the gene NFKB1 and Venous thrombosis.